Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon

Alaa M Alaqeel; Nuha A Alfurayh; Alanoud A Alhedyani; Saad M Alajlan

doi:10.1016/j.jdcr.2016.06.005

Sirolimus for treatment of kaposiform hemangioendothelioma associated with Kasabach-Merritt phenomenon

JAAD Case Rep. 2016 Dec 5;2(6):457-461. doi: 10.1016/j.jdcr.2016.06.005. eCollection 2016 Nov.

Authors

Alaa M Alaqeel¹, Nuha A Alfurayh¹, Alanoud A Alhedyani¹, Saad M Alajlan²

Affiliations

¹ College of Medicine, King Saud University, Riyadh, Saudi Arabia.
² Department of Dermatology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia.

No abstract available

Keywords: KHE, kaposiform hemangioendothelioma; KMP, Kasabach-Merritt phenomenon; Kasabach-Merritt phenomenon; case report; kaposiform hemangioendothelioma; sirolimus; treatment; vascular.

Publication types

Case Reports